Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



FDA Green Light = Surprise Share Surge

Shares of Peregrine Pharmaceuticals soared up to 33% intraday before closing with a still impressive 19% gain, thanks to the announcement that the FDA green-lit bavituximab's phase 3 non-small-cell lung cancer trial. 

In this video, health-care analyst David Williamson discusses whether the FDA decision justified this type of bullish enthusiasm and whether Peregrine is doing right by investors in starting this trial, given bavituximab's phase 2 troubles.

Another topic health-care investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 

Follow David on Twitter: @MotleyDavid.

Read/Post Comments (4) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 20, 2013, at 8:23 PM, BSDetector wrote:

    A great example of the blind leading novice investors. Peregrine will NOT be funding the phase III trials; their partner will. Stay tuned over the next few weeks or months for the name of the partner.

    Amazing...these spins of yours.

  • Report this Comment On May 21, 2013, at 10:28 PM, raulia wrote:

    PPHM is not a risky investment anymore for the following reason.Data claimed to be messed up was not really messed up,It is possible that some rich partner were playing to replace the previous one.Any investment in Biotech under $5 into third face is not a risky investment PPHM will become risky between $50-$55.FDA green light means that there are enough evidence that trail will pass so they are just asking for safety which is very important.So,Unless PPHM play safety these horse rider will shoot the stock around $19-$22.So once pain is motley and their clients gain.It is better to hold it tight and squeeze so PPHM can quickly shoot towards $15.It's all green beyond this point..............

  • Report this Comment On May 22, 2013, at 7:33 PM, ThatVirginian wrote:

    When tax time comes you will have to have health care otherwise you will be fined, not many people realize that yet, around fueling time these healthcare companies are going sky high

  • Report this Comment On May 23, 2013, at 11:59 AM, BSDetector wrote:

    Watch for the POP! Obviously there will be a sonic boom when PPHM partners in the next few weeks and it breaks $8. A larger collective POP however will be heard across the country. The sound made when the entire gang of Motley Fool PPHM bashers pull their heads out of their asks.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2442904, ~/Articles/ArticleHandler.aspx, 8/25/2016 2:59:23 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,450.53 -30.95 -0.17%
S&P 500 2,172.07 -3.37 -0.15%
NASD 5,213.08 -4.61 -0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/25/2016 2:43 PM
PPHM $0.37 Down +0.00 -0.92%
Peregrine Pharmace… CAPS Rating: **